In b cells, stimulation by metabolic, hormonal, neuronal, and pharmacological factors is coupled to secretion of insulin through different intracellular signaling pathways. Our knowledge about the molecular machinery supporting these pathways and the patterns of signals it generates comes mostly from rodent models, especially the laboratory mouse. The increased availability of human islets for research during the last few decades has yielded new insights into the specifics in signaling pathways leading to insulin secretion in humans. In this review, we follow the most central triggering pathway to insulin secretion from its very beginning when glucose enters the b cell to the calcium oscillations it produces to trigger fusion of insulin containing granules with the plasma membrane. Along the way, we describe the crucial building blocks that contribute to the flow of information and focus on their functional role in mice and humans and on their translational implications.
Introduction
Insulin secreted by pancreatic b cells regulates postprandial storage and interprandial usage of energy rich nutrients. A relative or absolute lack of insulin results in diabetes mellitus, a disease that affects more than 400 million people around the world, and this number is expected to increase to 640 million by 2040. 1 The burden of this disease is immense and includes public health costs of treating diabetic patients, as well as personal costs related to serious complications. 2 More than 90% of all diabetics have type 2 diabetes mellitus (T2DM), which is characterized by obesity, insulin resistance, and eventually insufficient insulin secretion. 3 A genetic susceptibility, age, obesity, dietary habits, and a sedentary lifestyle most importantly contribute to the development of the disease. 4 It has been shown that the progressive nature of T2DM can be slowed down upon or reversed by lifestyle interventions. 5, 6 However, pharmacological agents are still prescribed to practically all patients, especially later during the course of the disease, to increase the deficient secretion of insulin from b cells, to improve its action on target tissues, or promote urinary glucose excretion by inhibiting its renal reuptake. 7 b cells couple stimulation by metabolic, hormonal, neuronal, and pharmacological factors to insulin secretion by at least 3 interconnected intracellular signaling pathways (Fig. 1) . After more than 4 decades of intensive research, by far the most investigated one is the so-called triggering pathway. It consists of several events starting with influx of glucose through glucose transporters, glucose metabolism increasing intracellular ATP concentration, and triggering closure of ATP-dependent K C channels (K ATP channels). The resulting decrease in K C efflux causes membrane depolarization, the consequent opening of voltage dependent calcium (Ca 2C ) channels (VDCC), and influx of Ca 2C ions. The resulting increase in the cytosolic concentration of Ca 2C ([Ca 2C ] C ) is tightly coupled to membrane potential changes and typically follows a characteristic temporal pattern in the form of oscillations, activating the secretory machinery and fusion of insulin-containing vesicles with plasma membrane. 8 This triggering pathway is essential, i.e. necessary, but not very efficient without so-called amplifying pathways which mainly affect the sensitivity of the secretory machinery to [Ca 2C ] C . More specifically, there seem to be a K ATP -independent Ca 2C -dependent and a K ATP -independent Ca 2C -independent amplifying pathway. 9, 10 In addition, nonnutrient secretagogues, i.e., neurotransmitters and hormones, activate membrane receptors and set into motion protein kinase A-and protein kinase C-dependent pathways (Fig. 1) . To complicate things further, both glucose-and non-nutrient secretagogues shape the triggering signal by influencing uptake and release of Ca 2C in intracellular stores.
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A large proportion of our knowledge about the abovementioned pathways comes from work on rodents, especially mouse models. Although the human and the mouse pancreas and islets of Langerhans share many common anatomic and physiologic characteristics, they are not the same. 12, 13 During the last decade, islets obtained from humans have been increasingly used and studies suggested many important functional differences between the human and the mouse b cells, so far mostly for the triggering pathway. Validating findings obtained in mice and studying functional similarities and differences between b cells from humans and mice may help us understand why some therapeutic and other interventions do not yield the expected results and to better choose the experimental approach when looking for new therapeutic targets. Thus, in the present review we aim to highlight some similarities and differences between the two species at different stages of the triggering pathway, from the most proximal event, i.e., entry of glucose into the b cell, to the most distal changes in [Ca 2C ] C (Table 1) .
Glucose transporters
Influx of glucose into the b cell through glucose transporters is the first step in GSIS and in the series of signaling events collectively termed stimulus-secretion coupling (SSC). In both mice and humans, glucose enters the b cell cytosol by facilitated diffusion through insulin-independent membrane-bound glucose transporters (GLUTs). Most of the glucose transporters expressed in mouse b cells are GLUT2, the type of carrier proteins with the lowest binding affinity and highest transport capacity for glucose (K m 17 mM). 14 The glucose transport rate is 20-50-fold greater than the rate of glucose phosphorylation by glucokinase.
14 Genetic inactivation of GLUT2 suppresses glucose uptake and GSIS in mouse pancreatic b cells. 15 In human b cells on the other hand, GLUT2 are almost completely dispensable, since GLUT1 and GLUT3 are far more abundantly expressed. 16 Uptake of 3-O-methylglucose was estimated at 2.2 and 2.9 mmol/min per liter intracellular space in humans 17 and at 3.0 and 4.8 mmol/min per liter intracellular space in rats at 5 and 10 mM glucose, respectively. 18 However, these data can hardly be directly compared since glucose uptake in human b cells was measured at 37 C while in rat b cells, experiments were performed at 15 C to slow down the process sufficiently to allow for accurate calculations. Glucose transport in mouse b cells has been assessed with a different protocol and compared with the rate in human b cells using the fluorescent glucose analog 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deo xy-D-glucose (2-NBDG). The uptake of 2-NBDG in 10 mM glucose at 37 C was approximately 0.8 nmol/ min/5 £ 10 4 cells in mice and approximately 0.9 nmol/min/1 £ 10 5 cells in humans. 19 The GLUT1 protein (encoded by SLC2A1 gene) displays 97.2% homology 1 between humans and mice and plays a principal role in human islets, since K m in GLUT1 is lower (7 mM) compared with GLUT2 (SLC2A2 gene, 82% homology) and more compatible with the dose-response curve for GSIS in human b cells. One of the most striking differences between mouse and human GLUT expression is the distribution of GLUT3 (SLC2A3 gene, 83.5% homology), which has the highest affinity to glucose (K m 1,8 mM) among all 3 glucose transporters expressed in pancreatic b cells. In mice, GLUT3 is expressed only at a background level, whereas it is as abundant as GLUT1 in human b cells, suggesting an equally important role for both transporters in the regulation of insulin secretion in humans. 20 Although GLUT 1 and GLUT3 are far more abundant in human b cells than GLUT2, the latter still seems necessary for normal GSIS. Namely, mutations in the GLUT2 gene cause the FanconiBickel syndrome manifested by hepatomegaly, Transient receptor potential  channels   TRPC1  TRPV2  TRPA1  TRPM2, TRPM3, TRPM4, TRPM5   TRPV4  TRPM2, TRPM4, ] C oscillations or no oscillations observed (for details see Table 3 ).
growth retardation, and renal syndrome. 21 Impaired GSIS in adults has only been reported in a few cases of Fanconi-Bickel syndrome. 22 On the other hand, a transient absolute requirement for GLUT2 for the control of insulin secretion in the first months of life exists, since neonates with Fanconi-Bickel syndrome have transient diabetes mellitus that disappears after 18 months of age. 23 
Cytosolic and mitochondrial metabolism
Rapid entry of glucose through glucose transporters ensures glucose sensing, meaning that the rate of glucose entry is proportional to blood glucose levels and it accounts for fast equilibration of glucose between the extracellular space and the cytosol. This enables glucose unrestrained access to glucokinase (GCK), the hexokinase isozyme found in both mouse and human b cells (GCK gene, 95.9% homology) that catalyzes the rate-controlling step in glucose metabolism. 24 GCK has more than a 20-times lower affinity for glucose compared with other hexokinases (K m 6-11 mM) and is not inhibited by its product, glucose-6-phosphate. 25 K m values in mouse and humans are very similar, reported at 7 mM and 7.9 mM, respectively. 26 Its sigmoidal glucose dependency guarantees optimal responsiveness at physiological glucose levels, since the inflection point of the sigmoidal curve (4-5 mM) is close to the physiological threshold for GSIS in b cells. Functionally, this positive cooperativity with glucose allows the enzyme to have increased sensitivity to fluctuations in blood glucose levels. 27 The values of Hill coefficients in mice and humans are practically identical (1.7). 26 At 5 mM and 10 mM glucose glucokinase activity was 0.38 and 0.60 mmol/-min per liter intracellular space in nondiabetic human b cells, respectively, 17 and similar to that seen in rodent b cells. 28 In another study, the rate of glycolysis in 6 and 12 mM glucose was estimated at 40 and 90 pmol/islet/h in mouse, respectively, and at 125 and 160 pmol/islet/h in human islets, respectively. 29 GCK exerts a unique regulatory role in b cell metabolism because the reaction it catalyzes is virtually irreversible. 26, 27 The functional reserve of GCK is low in b cells, since a decrease of only 50% of enzyme activity is tolerated. 30, 31 Therefore, GCK expression is indispensable for SSC in b cells. It has been demonstrated that homozygous GCK knockout mice develop lethal hyperglycemia. 32 In humans, the majority of approximately 200 known mutations in the GCK gene, including missense, non-sense, and splice site mutations, result in mild hyperglycemia that is usually discovered by routine examination. Based on these characteristics, diabetes associated with GCK mutations was included in the group of maturity onset diabetes of the young (MODY) and named MODY 2. 33 These mutations result in a GCK molecule that is less sensitive or less responsive to glucose. b cells in patients with these mutations have a normal ability to produce and secrete insulin, but expectedly a higher threshold (7-8 mM) for GSIS. In rare cases, when infants inherit mutations from 2 heterozygous parents, permanent neonatal diabetes mellitus can occur. 34 On the other hand, heterozygous activating mutations can lead to varying degrees of hyperinsulinemia and hypoglycemia. 35 These observations are the main reason GCK activators have been studied for more than a decade. Systemic GCK activators alter GCK's affinity to glucose and thereby decrease the threshold for GSIS, but their main drawback is their potential to provoke hypoglycemic episodes. Therefore, hepatoselective GCK activators that can overcome this side effect seem more appropriate candidates for treating T2DM. 36, 37 Since GCK controls the rate-limiting step in glucose metabolisms, its activity partially determines the pattern of [Ca 2C ] C oscillations and the consequent pulsatile insulin secretion from b cells. It has been suggested that the slower component of compound oscillations with a period of approximately 5-15 minutes reflects oscillations in glycolysis, whereas the fast component is due to electrical activity in pancreatic b cells (see below). The enzyme downstream from GCK, phosphofructokinase (PFK) with positive feedback regulation by its product fructose bisphosphate, is believed to be directly responsible for oscillatory glycolysis (and slow oscillations). However, if the glucokinase flux rate is too low or too high, glycolysis will be non-oscillatory. In other words, glycolytic oscillations occur only at intermediate levels of GCK flux rate. 38, 39 Evidence for the molecular events linking glucose-6-phosphate to ATP production in mice and humans is scarce. Glucose-induced hyperpolarization of the mitochondrial inner membrane in mice 40 is consistent with the production of pyruvate, its translocation into the mitochondrion, oxidative phosphorylation, activation of the electron transport chain, and translocation of protons across the mitochondrial membrane. 41, 42 Subsequent transient increase in the mitochondrial [Ca 2C ] is the consequence of a tightly regulated interplay between Ca 2C entry on one hand and Ca 2C buffering in the matrix and extrusion on the other hand. [41] [42] [43] [44] [45] [46] [47] Mitochondrial 53 On the other hand, impairing Ca 2C entry into the mitochondrion in mice failed to do so. 48 A detailed recent study revealing many aspects of coupling between glucose and mitochondrial metabolism in human islets unfortunately did not compare cytosolic and matrix [Ca 2C ] changes and thus at present, a direct comparison between the 2 species in this regard is impossible. However, the glucose-and calcium-dependent changes in ATP synthesis and insulin release indicate that the functional role of mitochondria in the signaling cascade is comparable in the two species. 54 Along this line of reasoning, we wish to point out a recent finding that is of relevance for what was stated above but also for later parts of this paper. Cytosolic ATP concentration ([ATP] C ) dynamics induced by the incretin hormone GLP-1 involved changes in mitochondrial potential and were found to be much better correlated between different cells in mouse than in human islets. 55 This is in contrast with the degree of GLP-1-induced coupling of ionic events, e.g., [Ca 2C ] C changes, between b cells in human islets 56 59 The regulatory subunits are termed SURs because they bind sulfonylureas and therefore play a key role in determining the pharmacological regulation of K ATP channels. Because K ATP channels transport K C with a greater tendency into a cell then out, they are named inward rectifiers. The assembly and trafficking of the channels has been described to be precisely regulated. Assembly occurs in the endoplasmic reticulum (ER) and only completely assembled and full length complexes are then transported to the plasma membrane and expressed on the surface, while incompletely assembled complexes are retained in the ER. 60 K ATP channel subunits display differences in their sensitivity to adenosine nucleotides. Intracellular ATP acts on Kir6.2 to decrease channel open probability, while MgADP increases channel open probability through the SUR1 subunit, a member of the ATPbinding cassette superfamily. 61 Therefore, changes in [ATP] C and [ATP] C /[ADP] C are believed to determine channel activity. 62 However, only fully assembled K ATP channels have a normal sensitivity to ATP. The Kir6.2 isoform alone forms a weekly ATP-inhibited K ATP channel (IC 50 100-200 mM), while reconstitution with SUR1 increases the affinity to inhibitory ATP (IC 50 5-10 mM). 63 Since K ATP channels are not voltage dependent, their current-voltage relation is linear, although the current increases very little at membrane potential above C20 mV. This primarily results from a voltage-dependent block of outward K C currents by internal Na C and Mg 2C . 64 The kinetic studies of K ATP channels showed channel openings grouped in bursts. The dominant effect of ATP is to reduce the number of openings per burst and to prolong the time when the channel is closed. Furthermore, high concentrations of phosphatidylinositol phosphate (PIP 2 ) reduce the sensitivity of K ATP channels to inhibitory ATP by increasing the number of K ATP channel openings. 65 The kinetics of the K ATP channel in human b cells qualitatively resemble those reported for rodent b cells. 58, 66 Due to the critical role K ATP channels play in insulin secretion, it is not surprising that polymorphisms in K ATP subunits alter the biophysical properties of the channel and can lead to both hypo-and hyperglycemia. 67 In humans, K ATP channel mutations that result in decreased K C currents cause persistent hyperinsulinemic hypoglycemia of infancy (PHHI). 68 Mutations can be found in either of the subunits that make up K ATP channels. Mild forms of PHHI associated with mutations in SUR1 produce K ATP channels that can be inhibited by ATP, but only poorly stimulated with MgADP. Severe forms of the disease have been associated with mutations that truncate SUR1 and block expression of the K ATP channels on the cell membrane. However, remarkable physiologic differences exist between human neonates missing K ATP channels and the K ATP channel knockout mice
). 61 In both PHHI and K ATP channel null mice loss of K C currents causes an elevated membrane potential and consequently increased [Ca 2C ] C , leading to an inappropriately high rate of insulin release and producing hypoglycemia. As in PHHI, KIR6.2 ¡/¡ and SUR1 ¡/¡ mice display hypoglycemia immediately after birth, however their hypoglycemia is transient and persists only during the first 2-3 days of life. 69 It seems that K ATP channel null mice become refractory to increased [Ca 2C ] C and develop a K ATP -independent mechanism for regulating insulin release. During adulthood, PHHI patients are hyperglycemic with high prevalence of diabetes, while K ATP channel null mice display normal insulin and glucose levels when fed ad libitum, and are hypoglycemic upon fasting and exhibit a mild intolerance toward i. p. injection of glucose. SUR1
¡/¡ islets lack the firstphase of insulin secretion and have an attenuated second-phase after stimulation with high glucose, while Kir6.2 ¡/¡ islets have a small first-phase of insulin secretion with no second phase. 61 Conversely, gain-of-function mutations result in neonatal diabetes characterized by an insulin secretory deficit and hyperglycemia. The first indication that overactive K ATP channels can produce neonatal diabetes came from transgenic mice expressing a Kir6.2 subunit lacking a segment of its N-terminus responsible for channel gating. Its deletion resulted in nearly constantly open K ATP channels that have a reduced sensitivity to ATP and hypoglycemic sulfonylureas. 70 Severe hyperglycemia is lethal within first weeks after birth. 71 In humans, missense activating mutations associated with neonatal diabetes were also found in the gene encoding the Kir6.2 subunit of the K ATP channel (KCNJ11). 67 Furthermore, activating mutations in SUR1 in mice and humans directly enhance MgATP activation of K ATP channel or indirectly alter channel gating and reduce ATP inhibition at Kir6.2.
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Leak channels
The consensus model of SSC predicts that closure of K ATP channels triggers membrane depolarization. However, according to the Nernst and GoldmanHodgkin-Katz equations, closure of K ATP channels alone is not sufficient for moving the membrane potential away from the equilibrium potential for K C , as long as the membrane is permeable to K C only.
Therefore, the presence of an additional inward current is needed to achieve depolarization by reducing K C permeability. Since the input resistance of b cells upon closure of K ATP channels is increased, the current needed for depolarization is likely small, however the identity of this current and its properties have not yet been fully elucidated. The most likely ion channel candidates for depolarizing and hypepolarizing currents can be classified in at least 4 different groups, transient receptor potential (TRP) channels, 2-pore domain potassium or K2P channels, NALCN channels and connexins. Unstimulated b cells are to some extent permeable to Na C and Ca 2C without activation of voltage-dependent Na C channels and VDCCs. 10 TRP channels are candidates for Na C or Ca 2C influx contributing to the depolarizing current. The number of different TRP channels expressed in b cells is large (TRPC1, TRPC4, TRPV1, TRPV2, TRPV4,  TRPA1, TRPM2, TRPM3 , and TRPM5) 74 and is likely to increase (Fig. 2) . The channels are to some extent differentially expressed in b cells of different species. In the following lines, only a few examples will be listed. On the one hand, they translocate to plasma membrane upon glucose stimulation and stimulation with insulin or insulin-like growth factors (TRPV2), resulting in Ca 2C influx and increased insulin secretion. 75 This positive feedback to increase insulin secretion may result in hyperinsulinemia, commonly found at early stage of type 2 diabetes. On the other hand, knockdown of a specific insulin receptor attenuated insulin-induced translocation of TRPV2 and knockdown of TRPV2 channels and reduces GSIS. 75 In addition to glucose, other activators like islet amyloid polypeptide (TRPV4), 76 inflammatory mediators, glibenclamide (TRPA1), 77 pregnenolone sulfate, as well as clotrimazole and tamoxifen and structurally related compounds (TRPM3), [78] [79] [80] or steviol glycosides (TRPM5) 81 can enhance b cell function. Among all TRP channels present in b cells, the TRPM5 seems to play the most important role in insulin secretion since TRPM5 knockdown mice showed significantly reduced Ca 2C -activated nonselective cation current. Furthermore, glucose-induced oscillations of membrane potential and [Ca 2C ] C were reduced, particularly due to a lack of fast Ca 2C oscillations. 81 Consequently, glucose-induced insulin secretion from TRPM5 knock-down mice was reduced, resulting in impaired glucose tolerance. 81, 82 Lately, another group of hyperpolarizing currents have entered the stage as fine tuners of GSIS, namely K2P channels. Inhibition of the 2-pore-domain acidsensitive potassium channel (TASK-1) significantly stimulates both human and mouse b cells. 83 Likewise, ablation of TWIK-related alkaline pH-activated K2P (TALK-1) also seems to result in b cell membrane depolarization. 84 These studies suggest that these 2 K2P channels play a role in limiting glucose-stimulated depolarization and insulin secretion. At least in the case of TALK-1, an intracellular binding partner, osteopontin, has recently been described, however its function is not well understood. 85 Another candidate responsible for membrane depolarization after closure of KATP channels is the so called voltage-independent non-selective Na C leak channel (NALCN), 86 but its precise role in insulin secretion from mouse and human b cells still has to be elucidated.
Finally, with K ATP and other K C channels closed, the mere presence of electrical coupling between b cells via Cx36 gap junctions can serve as a source of possible electrical interference. More specifically, currents from less or more excitable neighboring cells can respectively hyperpolarize or depolarize a given cell, leading to a complex electrical activity pattern.
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Voltage-dependent calcium channels
Since both human and mouse b cells maintain a resting membrane potential at -70 mV or lower, closure of K ATP channels and the subsequent decrease in K C efflux depolarize the membrane. When membrane potential exceeds the threshold potential ( -50 mV), the open probability for voltage dependent calcium channels (VDCCs) increases. A number of differences exist between mouse and human VDCCs (Fig. 2) . In mouse b cells, whole-cell Ca 2C currents are activated by depolarization to potentials more positive than -50 mV, increase to a maximum at about -20 mV, and reverse at about C50 mV (in the presence of 2.6 mM Ca 2C ). 92 In human b cells, the Ca 2C current can be measured during depolarization to -50 mV and above with maximal amplitude at 0 mV. 93 The major VDCC subtype expressed in mouse b cells are L-type Ca 2C channels (Ca v 1.2), which account for more than 50% of all Ca 2C currents. Pharmacological inhibition and genetic ablation of the channel result in a severe reduction of GSIS during both first and second phase. 94 98 T-type VDCCs in human b cells is the only low-voltage activated calcium channel activated already at -60 mV, compared with high voltage-activated L-type and P/Q-type channels. T-type VDCCs reach their peak conductance at -30 mV and undergo fast voltage-dependent inactivation, which is half-maximal at -65 mV. 98 Differences between the roles VDCCs play in mouse and human b cells are illustrated in Fig. 2 and 3 .
Voltage-dependent sodium channels
Mouse b cells possess Na V 1.3 (Scn3a) and Na V 1.7 (Scn9a) channels, with Na V 1.7 being the quantitatively more important type. Knockout of Scn9a lowers Na C current by >85%, disclosing a small Scn3a-dependent component. 100 Inactivation of Na V 1.7 current is halfmaximal at ¡105 mV while inactivation of Na V 1.3 current is half-maximal at ¡50 mV and thus the latter likely contributes to action potential (AP) firing. A contribution of Na C channels to AP firing in mouse b cells is further corroborated by the finding that the specific sodium channel blocker tetrodotoxin (TTX) reduces the height of APs. 101 Scn3a is obviously important in insulin secretion, since genetic ablation of Scn3a reduces insulin secretion, while genetic ablation of Scn9a does not affect insulin secretion. 100 Taken together, these data suggest that Na V 1.3 represents the functionally more important Na C channel subtype in mouse b cells. Human b cells also possess voltage-dependent Na C channels that are responsible for the AP upstroke 102 ( Fig. 3) . The total Na C current in human b cells activates instantaneously by depolarization to -30 mV and above, reaches a maximal amplitude at 0 mV and inactivates with a time constant of 2 ms. 103 Sodium channels in human b cells undergo voltage-dependent steady-state inactivation that is half-maximal at -40 mV. 93, 99, 101 This is >50 mV more positive than in mouse b cells where the quantitatively more abundant Snc9a sodium channels are fully inactivated already at the resting membrane potential (-80 mV) and therefore, in contrast to humans, cannot effectively contribute to the oscillatory pattern of membrane potential (see below). Na V 1.6 channels probably account for the major part of Na C current in human b cells, and they are important for GSIS since secretion elicited by 6 and 20 mmol/l glucose is reduced by 70% and 55%, respectively, in the presence of TTX. 93 Furthermore, TTX reduces the AP amplitude by »10% and prolongs their duration. 104, 105 Like in mice, human b cells also express Na V 1.7 channels (SCN9a gene, 92% homology), but they account for only 25% of all Na C channel transcripts, 106 inactivate at hyperpolarized voltage ( -105 mV), and are thus not involved in AP firing. 
Voltage-or calcium-dependent potassium channels
In human b cells, the voltage-dependent potassium current consist of at least 2 different components. 93 BK channels which show both voltage-and Ca 2C -dependence 107 are responsible for a transient component activated rapidly upon membrane depolarization above -40 mV and with peak amplitude at C30 mV. 93 Above C30 mV, amplitude decreases due to reduced Ca 2C entry. Blockade of BK channels increases AP amplitude in human b cells, while in mouse b cells BK channels do not seem to play a major role in electrical activity and insulin secretion. 108 The second component of voltage-dependent potassium current is due to delayed rectifying K C channels. In mouse b cells mainly K V 2.1 are expressed, while in human b cells mRNA expression levels suggest that K V 2.2 channels are more abundantly expressed than K V 2.1 93 but latter has not been confirmed by electrophysiological measurements. In K V 2.1 null mice, glucose-induced AP duration is prolonged while the firing frequency (see below) is reduced. 109 Genetic silencing or pharmacological inhibition of K V 2.1 revealed > 70% reduction of K V currents comparing to those from control experiments. [109] [110] [111] Furthermore, ablation of K V 2.1 improves glucose tolerance and enhances insulin secretion in mice. 109, 110 On the other hand, pharmacological inhibition of K V 2.x currents failed to reduce glucose levels in vivo, moreover a significant reduction of K V 2.2 mRNA levels were observed and glucose-stimulated somatostatin release was enhanced. The later seems to be a reason for paracrine inhibition of insulin secretion and no significant effect on blood glucose lowering in vivo. 110 The same mechanisms might be involved in insulin secretion from human b cells since K V 2.x inhibitors, like GxTX-1E and Ry796, profoundly enhance GSIS and somatostatin release in human islets in vitro. 110 Furthermore, pharmacological inhibition of K V 2.1/2.2 currents using whole-cell patch-clamp suppresses K V currents in human b cells 93, 110 while has a week effect on electrical activity; it increases the half-width of APs, while it has no effect on action potential amplitude. 93 Regarding the effect on insulin secretion, the impact of K v 2.1/2.2 in human b cells is controversial. While previously mentioned study clearly shows enhanced GSIS during pharmacological inhibition of Kv2.1/2.2, no effect on insulin secretion is found in stromatoxin treated islets. 93 This different effect on insulin secretion and AP firing between mouse and human b cells may be due to the longer AP duration in mouse compared with human b cells, which results in a greater amount of K V 2.1 current being activated. 112 In human b cells the time constant of activation measured at -20 mV when BK channels are active and when K V 2.1/2.2 channels are active were 2 ms and >10 ms, respectively. 98 This indicates that K V 2.1/2.2 channels do not even activate during the AP upstroke (Fig. 3) and therefore blocking them does not affect electrical activity and insulin secretion. 98 In addition to K V 2.1 and K V 2.2 channels, K V 11.1 (ERG channels) are expressed in mouse and human b cells (KCNH2 gene is also named ether-a-go-gorelated gene, 96.4% homology). Selective blockage of hERG K C channels increased firing frequency and insulin secretion in human b cells. 113 Similarly, blocking ERG1 increases [Ca 2C ] C and therefore promotes insulin secretion also in mouse b cells. 114 Furthermore, ERG channels are responsible for long-lasting tail currents and may thus influence the intervals between spikes. 98 In the heart, hERG1 channels are the molecular basis for the so called long QT-syndrome, and some genetically determined hyperinsulinemias might involve mutations of hERG channels. 113 Beside the abovementioned voltage-dependent potassium channels, both mouse and human b cells also possess small conductance (SK) Ca 2C -activated K C channels 98, 112 (Fig. 2 ). SK3 and SK4 channels were found in human b cells. 98 Their activity is proposed as the underlying mechanism controlling the bursting pattern (see below). The silent phase between subsequent bursts is attributed to activation of potassium permeability, since blocking SK channels stimulates continuous AP firing.
115 A similar effect was observed in mouse b cells which express SK4 channels (KACNN4 gene, 87.7% homology). 116 The pattern of membrane potential oscillations
Since the first description of membrane potential changes in mouse b cells upon stimulation with glucose, 117 numerous studies on mice using different experimental paradigms have confirmed that glucoseinduced membrane potential changes in b cells occur in the form of bursts of APs (spikes), which follow a fast, a slow, or a combined pattern coined compound oscillations (Fig. 4B) . [118] [119] [120] [121] In human b cells, glucose-induced electrical activity is much more variable compared with mice, with continuous or irregularly spaced APs without any clear bursts reported in the majority of studies 93, 104, 105, 122 (also termed the canine-like pattern, Fig. 5 B, upper  trace) , or a more organized oscillatory electrical activity with Ca 2C -dependent (rodent-like) or Na C -and Ca
2C
-dependent (distinctly human) bursts being observed in other preparations from the same studies or in other studies. 104, 122, 123 Of note, the bursts of APs are typically much shorter in human b cells than in mice and this pattern has also been termed complex APs or rapid bursts (Fig. 5A, upper trace) . 104, 118, 124 In high concentrations of glucose, small amplitude oscillations of membrane potential without any clear APs (the so called wobbly pattern) have also been described (see Table 2 for details).
Irrespective of the species, oscillations in membrane potential reflect a balance between activation of Na determined by L-type Ca 2C channels responsible for the upstroke phase, and voltage-dependent potassium current through K v 2.1 channels responsible for the repolarization. In human b cells, AP upstroke is mediated by voltage-dependent sodium channels and L-type Ca 2C channels 102 while BK channels are mainly responsible for the repolarization phase. 93, 98, 104 Because of the kinetic differences between VDCCs and voltagedependent sodium currents, APs in mouse b cells are much longer compared with human b cells. The silent phase between subsequent bursts is attributed to SK channels for mouse, and to HERG, 103, 113 and SK channels for human b cells. 104 Additionally, it has been suggested that K ATP and T-type Ca 2C channels might play a role in grouping of APs into rapid bursts in human b cells. 98 Importantly, in human b cells that do not display bursting and continuously spike, the role of SK channels seems to depend on excitability of the cell, with less excitable cells showing an increase in AP firing frequency and more excitable cells not being affected upon SK channel block. 104 In non-stimulatory glucose, b cells are electrically silent. While in mice membrane potential oscillations In 10 glc, membrane potential progressively rised (to a background Vm of -35 mV) and the phenotype changed from i) to iii); the provided recordings are not long enough to reliably assess slow oscillations.
TTX nearly abolished rise in insulin secretion in 6, but had no effect in 10 glc. In mice (Fig. 4) , increasing glucose concentrations changes burst duration from 3 seconds and a frequency of 2-5 oscillations/min (i.e., period of 12-30 seconds) at the threshold concentration to a continuous spiking activity in 20 mM glucose 98, 119, 121, 125, 126 As already mentioned, in humans, the responses take several different forms at a given concentration of glucose and are much harder to predict (Fig. 5 and Table 2 ). For a comprehensive summary of possible patterns of membrane potential changes and factors that might influence them, in Table 2 we briefly review the main findings of all studies that have, to the best of our knowledge, described or even quantified the electrophysiological responses of human b cells to glucose and some other secretagogues (that act via the triggering pathway). All electrophysiological studies on human b cells taken together suggest that with increasing glucose, there is progressive depolarization also in human b cells and that there is at least circumstantial evidence of a trend of patterns switching from no APs to bursts of APs to continuous bursting. 99, 127 Finally, slow or the so-called glycolytic oscillations in membrane potential with a frequency of 0.2-0.4 oscillations/min are observed in mouse b cells under intermediate GCK flux rates and they are not glucose-sensitive. 38 In almost all studies on human b cells, the electrical activity was observed over periods that were too short to enable a reliable assessment of slow oscillations. However, a recent study by Riz et al. provided evidence that slow membrane potential oscillations with a period of 3-5 minutes can be present in human b cells and that they can be accounted for in the model by a glycolytic component. 104 ] C waves spreading between cells which we describe in more detail in the following chapter, and putatively also by diffusion of small signaling molecules and metabolic intermediates.
Coupling between b cells
Electrophysiological approaches estimated the gap junctional conductance between 2 b cells at about 200-350 pS in mice, 128, 129, 134 and at about 100-200 pS in humans. 135 Taking into account that each b cell is connected to 6 -8 neighbors, 136 the conductance between a cell and all of its neighboring cells was estimated at about 2.5-3.5 nS in mice. 137 Recently, gap junctional coupling between b cells has been explored by using fluorescence recovery after photobleaching (FRAP) and this approach suggested a quantitatively similar degree of coupling between b cells in human and mouse islets. 138 Gap junctions are permeable to a variety of ions and metabolites. 139 The most probable candidate for gapjunctional currents in mice are Ca 2C ions, as their flow through gap junctions is belived to be able to spread depolarization from a cell to its neighbors, 134, 140, 141 although this view has been challenged. 142 Conceivably, in humans both Na C and Ca 2C ions could be implicated in waves of depolarization, but this remains to be demonstrated. Noteworthy, gap junctions are permeable to glycolytic intermediates and their diffusion could account for synchronization of metabolic oscillations in different cells, although this is not necessary and electrical coupling alone can synchronize metabolic oscillations. 143 In addition to gap junctions, other means of cellcell communication, may help control insulin release from b cells. First, ephrin-A-EphA ligand-receptor signaling between b cells has a role in insulin secretion as glucose stimulation enhances insulin secretion via dephosphorylation of the Eph receptor in both mice and humans. 144 In addition, disruption of neural cell adhesion molecules (NCAM) seems to influence regulation of insulin release in mice. 145 Further, primary cilia of b cells may be involved in the control of insulin release in both mice and humans. 146, 147 Moreover, there are several possible auto-and paracrine interactions in both human and mouse islets. 148 Insulin secreted by b cells binds to insulin receptors on plasma membrane and acts in an auto-or paracrine manner by upregulating insulin gene transcription 149 and triggering exocytosis. 150 Further, ATP co-secreted with insulin, [151] [152] [153] binds to membrane-bound purinergic P2X and P2Y (for a review of the expression in mice and humans, see ref. 154 ). In mice, purinergic stimulation seems to have either an excitatory effect via P2X1 and P2X3 155 or an inhibitory effect via P2Y1 receptors. 156, 157 ATP was also suggested as an agent synchronizing b cell activity. 158 In fact, brief (15 seconds-long) stimulations by ATP were able to synchronize Ca 2C oscillations in isolated individual islets that were not in direct physically contact. 158 In humans, purinergic stimulation evokes a positive feedforward mechanism, 155, 159 most probably via P2X3 receptors 160 and a transient increase in [Ca 2C ] C . 161 Dopamine, yet another molecule co-secreted with insulin, was shown to inhibit GSIS in both humans and mice. 162, 163 In contrast, g-Aminobutyric acid (GABA), which is also co-secreted with insulin, was ascribed a positive feedback role in humans. 164, 165 Finally, glucagon secreted by a cells was found to synchronize oscillatory Ca 2C activity of b cells in mice, however the exact role of glucagon as a synchronizing factor needs to be explored into more detail as glucagon exhibits out-of-phase oscillations with insulin. 148, 166, 167 At the level of an islet, things are further complicated by the fact that somatostatin released from delta cells might critically influence the function of both b and a cells. 11 Finally, coupling between b cells from different islets might conceivably play a role in vivo and be brought about by means of neurotransmitters, such as acetylcholine, [168] [169] [170] or via metabolic feedback from the liver. 143 The relationship between membrane potential and [Ca 2C ] C changes, waves, and functional connectivity Twenty years after the first description of glucoseinduced membrane potential changes in microdissected mouse islets, 117 ] C oscillations are closely matched by pulses of insulin secretion. [174] [175] [176] [177] A large number of studies using different electrophysiological and imaging approaches support the view that membrane potential and [Ca 2C ] C changes in different b cells in mouse islets are not completely in phase, but phase-locked with a temporal delay and this delay can be explained by depolarization and [Ca 2C ] C waves spreading from cell to cell via gap junctions. 134, 140, 141, 172, [177] [178] [179] [180] [181] [182] Further, both waves spread in the same direction and with the same velocity and in every b cell [Ca 2C ] C oscillations closely follow the bursts of electrical activity but are of longer durations than the bursts (Fig. 4C) . 141, 183, 184 All studies that have quantified the direction and velocity of [Ca 2C ] C waves have reported comparable values of wave velocities and also agree in that at least over the time frame of a few minutes, the direction of the waves remains rather constant. 140, 141, 182, 185 Moreover, experiments and existing mathematical models suggest that the origin of the wave is usually a single cell or a small cluster of cells at islet periphery, also called the pacemaker region, that heterogeneity in b cell excitability and gap junction coupling is needed to fully reproduce the experimentally observed properties of synchronicity and [Ca ] C oscillation period for the rest of the islet, and that such regions might arise by chance due to heterogeneity. 182, 185 As to why [Ca 2C ] C waves usually originate at islet periphery, considering that cells with elevated excitability can probably be found in all regions of an islet, we wish to suggest that this might be due to a lower number of neighboring cells and thus a weaker hyperpolarizing contribution from less excitable cells. ] C wave could allow for such behavior. This conflict has received yet another layer of complexity with the recent report by Johnston and colleagues suggesting that hub cells are in fact bona fide pacemakers that convey signals to other cells called followers. 186 In comparison with the more traditional view of synchronization via waves, according to the functional coupling analysis, there seems to be more pacemakers (1-10% of all b cells) and they are not limited to the periphery but are distributed across the whole cross section of an islet.
In our opinion, the above 2 ideas are not mutually exclusive. Namely, it is possible that there is a temporal sequence of activation within the population of hubs, such that they are activated one after another and before other cells and that the depolarization and [Ca 2C ] C wave spread to follower cells from them. A study seems to support the idea presented above. 187 Namely, cellular heterogeneity and nearest neighbor coupling, without any additional direct long range physical connections (via nerves or cilia, see above), are sufficient to account for both the properties of experimentally observed membrane potential and [Ca 2C ] C waves and the degree of synchronization they enable, 140, 141, 172, 178, 180, [182] [183] [184] [185] and the small-world character of the functional connectivity pattern with hubs and followers. 56, 88, 186, [188] [189] [190] In this model, in 3D there are strings of more strongly coupled direct neighbors that enable propagation of fast [Ca 2C ] C waves over long distances, and enable a high degree of synchronicity between widely separated cells that thus assume the role of hubs when studied from the functional network perspective. The remaining cells are less well coupled to hubs and to each other and thus their signals correlate with each other to a lesser extent, making them less well connected in the functional network. 187 This model is also consistent with our report of segregated communities of nearby cells that become more and more interconnected in higher glucose, when gap junctional connectivity is believed to increase, 188 and also with reports of decreased connectivity when gap junction coupling is reduced (see below for details). 56, 186 There are certainly several open questions regarding connectivity in general and the nature of hub cells in specific and they have been recently summarized in a comprehensive review. 190 Here we only wish to point out that in accordance with predictions, 182, 185 evidence is accumulating that the hub or pacemaker cells are metabolically highly active, 186, 191 and display some phenotypic characteristics of immature cells, such as high levels of glucokinase, a low insulin content and a low expression of pancreatic duodenum homeobox-1 (Pdx1) and NK6 homeobox 1 (Nkx6.1). A less mature phenotype is also consistent with a lower threshold for insulin secretion. 192 Notably, immature cells can indeed be found in varying numbers in adult islets of Langerhans. 193 However, considering the role of gap junctions in b cell connectivity and the finding that adult b cells express more Gjd2 (the gene encoding Cx36) and that the expression of this gene has been linked with an increased expression of transcription factors determining a mature b cell phenotype, 194 hub cells are probably not phenotypically immature in all regards.
For several reasons, much less is known about normal patterns of [Ca 2C ] C changes, waves, their relationship with depolarization, and also about functional connectivity in human islets. 45, 195, 196 First, human pancreatic tissue is more difficult to obtain than mouse tissue, and in a large proportion of the few existing studies, it has been collected from patients with pancreatic disease. Second, islets have been isolated in different ways and the culture duration and conditions have varied widely in studies on human islets, which is a possible source of phenotypic variability in their responses to glucose, as has been demonstrated convincingly for mouse islets. 197 Finally, [Ca 2C ] C changes have been recorded by different methods and different stimulation protocols have been used in studies on human islets. Table 3 provides a comprehensive summary of the various aspects discussed above in more detail. In brief, at the one end of the spectrum of possible scenarios lies the view that human islets do not display organized fast [Ca 2C ] C oscillations and that even if they occasionally occur, they are synchronized only locally. 198 Putatively, the structural substrate of this behavior is the unique cytoarchitecture of human islets, where b cells are believed to be less orderly distributed within islets and make a larger number of heterotypic contacts with a and delta cells than in mouse islets. 198, 199 At the other end, we have the possibility that human islets display orderly fast [Ca 2C ] C oscillations (albeit with a lower frequency) that are at least partially 200 or even completely synchronized between different cells. 201 These 2 types of responses seem to be supported by morphological studies showing that in human islets, b cells are organized in clusters 202 or ribbon-like patterns, 203 and that in 3 dimensions they probably form uninterrupted syncytia and sometimes even islets that are similar to the stereotypical mouse mantle-core islets. 12, 204, 205 Between these 2 extremes lie the reports of [Ca 2C ] C oscillations that were slower, less orderly, or were not observed in all islets included in a study (Table 3) . Noteworthy, in a few recent studies synchronization of [Ca 2C ] C signals in different cells has been analyzed in human islets and compared with mouse islets. The percentage of area synchronized 206 was similar in mouse and human islets 138 and human islets showed similar but more clustered functional connectivity. 56, 186 It remains to be determined whether these different phenotypes reflect true biological variability or are at least partly due to methodological factors. Additionally, the presence of waves, the coupling between membrane potential and [Ca 2C ] C changes, as well as between [Ca 2C ] C and insulin secretion, remain to be investigated into more detail. Recently, evidence has been provided that b cells in human islets electrically communicate with each other similarly as in mice, but it remains to be explained how exactly the observed extracellular slow potentials relate to membrane potential oscillations. 207 Furthermore, it is difficult to understand how the described properties of [Ca 2C ] C oscillations can be reconciled with patterns of electrical activity in human islets. The rapid bursts are too rapid to explain the observed periods of [Ca 2C ] C oscillations and it is also unclear whether they are synchronized between different cells. The recently observed slow membrane potential oscillations seem to be a better candidate for explaining [Ca 2C ] C oscillations observed in human islets in one study, 104, 200 although they are too slow to explain the faster [Ca 2C ] C oscillations observed in another. 201 Moreover, the release of insulin from isolated human islets occurs in a fairly regular pulsatile manner, with a period between approximately 4 and 10 minutes, 208, 209 and it remains to be clarified how the irregular patterns of membrane potential and [Ca 2C ] C are compatible with this finding. Noteworthy, the recently reported period of slow glycolytic membrane potential oscillations in b cells 104 could explain the period of insulin secretory pulse at the lower bound of the reported range. 209 . Fig. 5 illustrates the 2 abovementioned extremes of possible scenarios.
Changes in coupling, membrane potential and Ca oscillations, as well as functional connectivity in type 2 diabetes
There is currently no direct evidence for an involvement of disrupted coupling in pathogenesis of T2DM in humans. Yet, a body of circumstantial evidence suggests that disrupted coupling could play an important role. On the one hand, diminishing or abolishing gap junctional coupling by pharmacological or genetic tools in mice leads to a disrupted pattern of membrane potential and [Ca 2C ] C oscillations, as well as to an absence of [Ca 2C ] C waves. 87, 182, 185, 210 Further, some studies have found an increased basal insulin secretion and a diminished amplitude of the first phase, as well as absence of oscillations in secretion during the second phase of stimulated insulin secretion from islets lacking gap junctions. 210, 211 These alterations in insulin secretion from isolated islets have not been supported by all studies. 210, 212 However, measurements in Cx36 knockout mice in vivo strongly support the view that first phase insulin secretion is reduced and the second phase is non-oscillatory in these animals, which could account for the observed glucose intolerance. 211 On the other hand, chronically increased glucose has been shown to decrease expression of Gjd2 and this may contribute to the effect of glucotoxicity. 213 Similarly, lipotoxicity has been shown to involve Cx36 downregulation. 56 In addition, cytokines released from the adipose tissue and in islets under hyperglycemia and hyperlipidemia are able to significantly decrease Cx36 gap junction coupling, disrupt the synchronicity and pattern of [Ca 2C ] C oscillations, and reduce the number of hubs and correlated links. 138, 186, 214 Most importantly, it has been demonstrated in high-fat diet fed mice that a prediabetic milieu leads to an increase in basal insulin secretion, an impairment in Cx36 mediated intercellular ] C oscillations in islets isolated from these mice. 56 Similar findings have been obtained on islets from ob/ob 216 and db/db 217 mice. In sum, it seems that the series of events connecting altered gap junctional coupling with impaired glucose tolerance via a disrupted pattern of synchronization of membrane potential and [Ca 2C ] C oscillations operate both ways in mice. In other words, diminished coupling can result in glucose intolerance and vice versa.
Regarding the relevance of this series of events for humans, disruptions to insulin dynamics similar to the ones described above are observed in humans with prediabetes and T2DMs. 218, 219 Moreover, chronic exposure of human islets to elevated free fatty acids reduces Cx36 expression, disrupts the synchronicity of the [Ca 2C ] C response, functional connectivity, and insulin release in response to GLP-1 added to stimulatory glucose (but not to stimulatory glucose alone). Importantly, donor BMI seems to be negatively correlated with islet responses to GLP-1. 56 It was further demonstrated that proinflammatory cytokines decrease Cx36 gap junction coupling in isolated human islets, albeit in a spatially more uniform manner that in mouse islets, 138 and that glucolipotoxicity induces hub failure in isolated human islets, i.e., it reduces the number of hubs and functional links between b cells. 186 The above recent lines of evidence suggest that similar although not same pathophysiological mechanisms linking glucose intolerance and gap junctional coupling might be at work in humans. It has been proposed that inherent structural differences between human and mouse islets 12 might explain the differences in the spatial pattern of cytokineinduced Cx36 downregulation, 138 and that in addition to the inherent differences in islets, patterns of meal consumption might account for the differential responsiveness of human and mouse islets to glucose and incretins. 56 To get a more complete picture of b cell connectivity as a target of various pathological processes and future therapies, see some resourceful recent reviews. 91, 189, 190, 196, 220 Conclusions At all levels of the triggering pathway to insulin secretion, from the entry of glucose into b cells to the pattern of [Ca 2C ] C changes that are believed to trigger insulin release, there are important functional differences between mice and humans. At present, our knowledge about these differences is largely limited to the types and functional properties of transporter and channel proteins being expressed in the 2 species, whereas there is still much confusion regarding the normal or prevailing patterns of membrane potential and [Ca 2C ] C changes and intraislet synchronization of these 2 crucial signals in the signaling cascade, especially in human islets. Even less is known about the mechanisms of interislet synchronization in mouse and human islets that are believed to govern the in vivo oscillations in plasma insulin concentration. In addition, we deliberately limited ourselves to functional aspects in adults and developmental facets were only touched upon. The accumulating evidence regarding interspecies similarities and differences in other pathways to insulin secretion and the role of neurotransmitters, paracrine factors from other islet cells, and hormones, such as incretins, deserves separate reviews.
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